Optimal Exercise Programs for Patients with Peripheral Artery Disease: A Scientific Statement from the American Heart Association

Diane Treat-Jacobson; Mary M. McDermott; Ulf G. Bronas; Umberto Campia; Tracie C. Collins; Michael H. Criqui; Andrew W. Gardner; William R. Hiatt; Judith G. Regensteiner; Kathleen Rich

doi:10.1161/CIR.0000000000000623

Optimal Exercise Programs for Patients with Peripheral Artery Disease: A Scientific Statement from the American Heart Association

Diane Treat-Jacobson
, Mary M. McDermott
, Ulf G. Bronas
, Umberto Campia
, Tracie C. Collins
, Michael H. Criqui
, Andrew W. Gardner
, William R. Hiatt
, Judith G. Regensteiner
, Kathleen Rich

Department of Physical Medicine and Rehabilitation

Research output: Contribution to journal › Article › peer-review

248 Scopus citations

Original language	English (US)
Pages (from-to)	E10-E33
Journal	Circulation
Volume	139
Issue number	4
DOIs	https://doi.org/10.1161/CIR.0000000000000623
State	Published - Jan 22 2019

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIR.0000000000000623

Cite this

Treat-Jacobson, D., McDermott, M. M., Bronas, U. G., Campia, U., Collins, T. C., Criqui, M. H., Gardner, A. W., Hiatt, W. R., Regensteiner, J. G., & Rich, K. (2019). Optimal Exercise Programs for Patients with Peripheral Artery Disease: A Scientific Statement from the American Heart Association. Circulation, 139(4), E10-E33. https://doi.org/10.1161/CIR.0000000000000623

@article{a1f5b47b1c42499eb30e82494f90c6d9,

title = "Optimal Exercise Programs for Patients with Peripheral Artery Disease: A Scientific Statement from the American Heart Association",

author = "Diane Treat-Jacobson and McDermott, \{Mary M.\} and Bronas, \{Ulf G.\} and Umberto Campia and Collins, \{Tracie C.\} and Criqui, \{Michael H.\} and Gardner, \{Andrew W.\} and Hiatt, \{William R.\} and Regensteiner, \{Judith G.\} and Kathleen Rich",

note = "Funding Information: AstraZeneca (clinical trial research grant to study ticagrelor in PAD)*; Bayer (clinical trial research grant to study rivaroxaban in PAD)†; Pluristem (clinical research grant of a stem cell product in PAD)*; NIH (multicenter clinical trial in venous thrombosis)† Funding Information: ACI Medical (supplied pneumatic compression devices for a pilot study)*; Chromadex (supplied drug for study)†; Hershey{\textquoteright}s Company (supplied drug for study)†; NHLBI (funding from 4 ongoing research grants)†; NIA†; PCORI†; Regeneron†; Reserveage (supplied drug for study on resveratrol)*; Viromed (supplied drug for study)†",

year = "2019",

month = jan,

day = "22",

doi = "10.1161/CIR.0000000000000623",

language = "English (US)",

volume = "139",

pages = "E10--E33",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Optimal Exercise Programs for Patients with Peripheral Artery Disease

T2 - A Scientific Statement from the American Heart Association

AU - Treat-Jacobson, Diane

AU - McDermott, Mary M.

AU - Bronas, Ulf G.

AU - Campia, Umberto

AU - Collins, Tracie C.

AU - Criqui, Michael H.

AU - Gardner, Andrew W.

AU - Hiatt, William R.

AU - Regensteiner, Judith G.

AU - Rich, Kathleen

N1 - Funding Information: AstraZeneca (clinical trial research grant to study ticagrelor in PAD)*; Bayer (clinical trial research grant to study rivaroxaban in PAD)†; Pluristem (clinical research grant of a stem cell product in PAD)*; NIH (multicenter clinical trial in venous thrombosis)† Funding Information: ACI Medical (supplied pneumatic compression devices for a pilot study)*; Chromadex (supplied drug for study)†; Hershey’s Company (supplied drug for study)†; NHLBI (funding from 4 ongoing research grants)†; NIA†; PCORI†; Regeneron†; Reserveage (supplied drug for study on resveratrol)*; Viromed (supplied drug for study)†

PY - 2019/1/22

Y1 - 2019/1/22

UR - https://www.scopus.com/pages/publications/85060197141

UR - https://www.scopus.com/pages/publications/85060197141#tab=citedBy

U2 - 10.1161/CIR.0000000000000623

DO - 10.1161/CIR.0000000000000623

M3 - Article

C2 - 30586765

AN - SCOPUS:85060197141

SN - 0009-7322

VL - 139

SP - E10-E33

JO - Circulation

JF - Circulation

IS - 4

ER -

Optimal Exercise Programs for Patients with Peripheral Artery Disease: A Scientific Statement from the American Heart Association

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this